INFORM | FIRST HALF YEAR OF 2021

As in the preceding quarters, the coronavirus pandemic has had a significant impact on HARTMANN's business devel- opment in the first half of 2021. After a high number of infections and strict contact restrictions in the first months, the situation normalized slightly towards the end of the reporting period, in particular thanks to rising vaccination rates. This development affected HARTMANN's business in several ways. The positive effects resulting from the coronavirus pandemic, which were clearly visible in 2020, declined considerably in the first half of 2021. In particular, demand for products from the Infection Management segment and personal protective equipment has fallen from the highs of the previous year. At the same time, the negative effects of the pandemic have largely persisted: budget and cost pres- sures in healthcare systems continue to intensify and are impacting the development of business, as is the still low room occupancy rate in hospitals and nursing homes. Only the slowly increasing number of surgeries towards the end of the first half of the year and the resulting renewed rise in demand for wound care products point to a slight recovery. Further challenges arose due to the indirect increase in costs caused by the coronavirus pandemic: Higher raw material prices had a negative impact on material costs – plus the increased freight and logistics costs. Overall, the first half of the year was characterized by a decline in sales and earnings compared to the previous quarters, as forecast. Compared to the same period of the previous year, HARTMANN recorded a moderate organic decline in sales of −5.0%. Across all business segments, sales amounted to EUR 1.153 billion. Adjusted EBITDA amounted to EUR 148.2 million and the adjusted EBITDA margin was 12.8%. Despite the challenging market and competitive envi- ronment, HARTMANN continued to steadily pursue its Transformation Program in the first half of 2021 – making solid progress in all key projects. The online nursing portal pflege.de, acquired at the beginning of the year, also progressed very positively. HARTMANN continuously reviews its planning and forecasts. Based on current calculations, the Company confirms the forecast for the current financial year made in the Annual Report 2020 and continues to assume a moderate or- ganic decline in sales and a declining adjusted EBITDA of EUR 210 to 260 million. Kind regards and take care! Britta Fünfstück